Login / Signup

Bortezomib-based four-drug induction does induce a response in advanced relapsed ALL but cure remains elusive.

Yoav H MessingerBruce C Bostrom
Published in: Pediatric blood & cancer (2019)
Keyphrases
  • multiple myeloma
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • diffuse large b cell lymphoma
  • hodgkin lymphoma
  • newly diagnosed
  • adverse drug
  • electronic health record